Dibash Kumar Das

454 total citations
39 papers, 340 citations indexed

About

Dibash Kumar Das is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dibash Kumar Das has authored 39 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dibash Kumar Das's work include Cancer-related molecular mechanisms research (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer Cells and Metastasis (3 papers). Dibash Kumar Das is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer Cells and Metastasis (3 papers). Dibash Kumar Das collaborates with scholars based in United States and India. Dibash Kumar Das's co-authors include Christopher Cardozo, Zachary Graham, Olorunseun O. Ogunwobi, Moira Sauane, Joseph R. Osborne, Jong Y. Park, Ashleigh M. Francis, Konstantinos Krampis, Brian D. Robinson and Bertal H. Aktas and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Dibash Kumar Das

33 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dibash Kumar Das United States 10 182 98 73 60 47 39 340
Danilo Piobbico Italy 15 261 1.4× 98 1.0× 62 0.8× 77 1.3× 41 0.9× 26 439
Maria Concetta Romano Italy 9 154 0.8× 64 0.7× 146 2.0× 72 1.2× 41 0.9× 13 370
Seongki Min South Korea 10 216 1.2× 112 1.1× 74 1.0× 36 0.6× 40 0.9× 13 325
Qing Luo China 9 150 0.8× 89 0.9× 84 1.2× 41 0.7× 77 1.6× 21 322
Xingning Lai China 9 233 1.3× 149 1.5× 44 0.6× 39 0.7× 40 0.9× 12 376
Wenhui Zhao China 13 262 1.4× 137 1.4× 36 0.5× 60 1.0× 42 0.9× 46 401
Mo Ping China 7 192 1.1× 103 1.1× 58 0.8× 73 1.2× 23 0.5× 9 366
Weifang Yu China 14 216 1.2× 110 1.1× 29 0.4× 80 1.3× 77 1.6× 30 427
Kehan Ren China 11 239 1.3× 121 1.2× 37 0.5× 39 0.7× 29 0.6× 23 378
Saien Lu China 11 273 1.5× 83 0.8× 38 0.5× 68 1.1× 34 0.7× 20 426

Countries citing papers authored by Dibash Kumar Das

Since Specialization
Citations

This map shows the geographic impact of Dibash Kumar Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dibash Kumar Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dibash Kumar Das more than expected).

Fields of papers citing papers by Dibash Kumar Das

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dibash Kumar Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dibash Kumar Das. The network helps show where Dibash Kumar Das may publish in the future.

Co-authorship network of co-authors of Dibash Kumar Das

This figure shows the co-authorship network connecting the top 25 collaborators of Dibash Kumar Das. A scholar is included among the top collaborators of Dibash Kumar Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dibash Kumar Das. Dibash Kumar Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Dibash Kumar & Steven L. Shafer. (2024). Remimazolam in Focus: Enhancing Anesthesia, Managing Risks. ASA Monitor. 88(5). 1–5. 2 indexed citations
2.
Das, Dibash Kumar & Steven L. Shafer. (2023). Revolutionizing Cancer Treatment: mRNA-Based Personalized Cancer Vaccine Shows Promise in Melanoma Therapy. ASA Monitor. 87(7). 1–4. 1 indexed citations
3.
Das, Dibash Kumar. (2022). Novel Mechanism Triggering Bone Metastasis in Ewing Sarcoma Identified. Oncology Times. 44(16). 20–20.
4.
Das, Dibash Kumar. (2022). Promising Deep Learning-Based CAD System for Cervical Cancer. Oncology Times. 44(14). 30–30. 2 indexed citations
5.
Toro, Carlos A., Jens Hansen, Mustafa M. Siddiq, et al.. (2021). The Human ApoE4 Variant Reduces Functional Recovery and Neuronal Sprouting After Incomplete Spinal Cord Injury in Male Mice. Frontiers in Cellular Neuroscience. 15. 626192–626192. 7 indexed citations
6.
Das, Dibash Kumar. (2021). Insights Into a Phased Approach to Breast Cancer Early Detection Programs. Oncology Times. 43(6). 15–16.
7.
Das, Dibash Kumar. (2021). An Overview of 8 Viruses That Can Cause Cancer. Oncology Times. 43(13). 10–11. 1 indexed citations
8.
Das, Dibash Kumar. (2020). CDK4/6 Inhibitors for Treatment of Metastatic Breast Cancer. Oncology Times. 43(1). 16–16.
9.
Das, Dibash Kumar, et al.. (2019). MicroRNA-4719 and microRNA-6756-5p Correlate with Castration-Resistant Prostate Cancer Progression through Interleukin-24 Regulation. Non-Coding RNA. 5(1). 10–10. 10 indexed citations
10.
Toro, Carlos A., Dibash Kumar Das, Dongming Cai, & Christopher Cardozo. (2019). Elucidating the Role of Apolipoprotein E Isoforms in Spinal Cord Injury-Associated Neuropathology. Journal of Neurotrauma. 36(24). 3317–3322. 6 indexed citations
11.
Das, Dibash Kumar, et al.. (2017). Fibronectin and androgen receptor expression data in prostate cancer obtained from a RNA-sequencing bioinformatics analysis. Data in Brief. 11. 131–135. 5 indexed citations
12.
Das, Dibash Kumar & Olorunseun O. Ogunwobi. (2017). Abstract 1473: miR-1207-3p regulates c-Myc in aggressive prostate cancer. Cancer Research. 77(13_Supplement). 1473–1473. 1 indexed citations
13.
Das, Dibash Kumar, et al.. (2016). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) activates caspases in human prostate cancer cells through sigma 1 receptor. Biochemical and Biophysical Research Communications. 470(2). 319–323. 16 indexed citations
14.
Das, Dibash Kumar, Jong Y. Park, Konstantinos Krampis, et al.. (2016). miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin. Experimental Cell Research. 348(2). 190–200. 48 indexed citations
15.
Das, Dibash Kumar, Joseph R. Osborne, Hui‐Yi Lin, Jong Y. Park, & Olorunseun O. Ogunwobi. (2016). miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer. Translational Oncology. 9(3). 236–241. 15 indexed citations
16.
Das, Dibash Kumar, et al.. (2015). A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis. Journal of Visualized Experiments. e52858–e52858. 1 indexed citations
17.
Das, Dibash Kumar, et al.. (2015). Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model. Journal of Visualized Experiments. 7 indexed citations
18.
XIAO, Shu Dong, Dibash Kumar Das, Zaineb Nadeem, et al.. (2014). Induced Expression of Nucleolin Phosphorylation-Deficient Mutant Confers Dominant-Negative Effect on Cell Proliferation. PLoS ONE. 9(10). e109858–e109858. 22 indexed citations
19.
Collisson, Eric A., Dibash Kumar Das, Andreas-Claudius Hoffmann, et al.. (2008). Use of whole genome expression analysis of pancreatic adenocarcinoma to predict prognosis after OXi4503 surgery. Journal of Clinical Oncology. 26(15_suppl). 4503–4503. 5 indexed citations
20.
Deo, S. V. S., Joydeep Purkayastha, N. K. Shukla, et al.. (2003). Intent of therapy in metastatic breast cancer with isolated ipsilateral supraclavicular lymph node spread--a therapeutic dilemma.. PubMed. 51. 272–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danilo Piobbico Breakdown of academic impact, for papers by Maria Concetta Romano Breakdown of academic impact, for papers by Seongki Min Breakdown of academic impact, for papers by Qing Luo Breakdown of academic impact, for papers by Xingning Lai Breakdown of academic impact, for papers by Wenhui Zhao Breakdown of academic impact, for papers by Mo Ping Breakdown of academic impact, for papers by Weifang Yu Breakdown of academic impact, for papers by Kehan Ren Breakdown of academic impact, for papers by Saien Lu
Rankless by CCL
2026